(D-Ala2)-β-Casomorphin (1-3) amide is a truncated opioid peptide derived from casein, with a D-alanine substitution at position 2 that enhances its receptor-binding stability. The peptide's amide group improves its resistance to enzymatic breakdown. Researchers use this analog to investigate opioid-like effects in the gastrointestinal system and to study its interactions with μ-opioid receptors.
CAT No: Q0616
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More